Related Experiment Video
Updated: May 19, 2026
08:59
An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
Published on: December 3, 2020
Liver expression quantitative trait loci: a foundation for pharmacogenomic research
Dylan M Glubb1, Neepa Dholakia, Federico Innocenti
1Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina at Chapel Hill Chapel Hill, NC, USA.
Frontiers in Genetics
|August 23, 2012
Summary
Expression quantitative trait loci (eQTL) analysis in liver tissue reveals genetic regulation of gene expression. This research provides a foundation for pharmacogenomics, enhancing drug metabolism and disposition studies.
Area of Science:
- Genomics
- Pharmacogenomics
- Molecular Biology
Background:
- Expression quantitative trait loci (eQTL) analysis offers insights into genetic regulation of gene expression.
- The liver's role in drug metabolism makes liver eQTL studies crucial for pharmacogenomics.
- Four genome-wide eQTL studies in human liver tissue have been conducted.
Purpose of the Study:
- To explore the utility of liver eQTL data in pharmacogenomics.
- To lay the groundwork for future pharmacogenomic studies by characterizing genetic regulation of gene expression in the liver.
- To identify liver-specific eQTLs and their potential impact on clinical phenotypes.
Main Methods:
- Genome-wide eQTL analysis using primary human liver tissue.
- Reproducibility assessment of identified liver eQTLs.
- Integration of eQTL data with genome-wide association studies (GWAS) for clinical interpretation.
Main Results:
- Numerous reproducible liver eQTLs have been identified.
- A subset of these eQTLs may be specific to liver tissue.
- Liver eQTL data has been used to interpret GWAS findings and identify genes influencing clinical phenotypes.
Conclusions:
- Liver eQTL data has significant, yet underexplored, potential in pharmacogenomics.
- Further research will enhance the characterization of genetic regulation of gene expression in the liver.
- This knowledge will provide a rational basis for prospective pharmacogenomic studies of various drugs.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...